334 related articles for article (PubMed ID: 17311283)
1. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
2. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling.
Iyer AK; Tran KT; Griffith L; Wells A
J Cell Physiol; 2008 Feb; 214(2):504-12. PubMed ID: 17708541
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
Holbrook MR; Slakey LL; Gross DJ
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
[TBL] [Abstract][Full Text] [Related]
5. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.
Sanderson MP; Dempsey PJ; Dunbar AJ
Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132
[TBL] [Abstract][Full Text] [Related]
6. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.
Higashiyama S; Iwabuki H; Morimoto C; Hieda M; Inoue H; Matsushita N
Cancer Sci; 2008 Feb; 99(2):214-20. PubMed ID: 18271917
[TBL] [Abstract][Full Text] [Related]
7. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
[TBL] [Abstract][Full Text] [Related]
8. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
Shin SY; Yokoyama T; Takenouchi T; Munekata E
J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
[TBL] [Abstract][Full Text] [Related]
9. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
Cortes-Reynosa P; Robledo T; Salazar EP
Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
13. Structure of the extracellular region of HER3 reveals an interdomain tether.
Cho HS; Leahy DJ
Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
[TBL] [Abstract][Full Text] [Related]
14. Role of extracellular matrix-cell interaction and epidermal growth factor (EGF) on EGF-receptors and actin cytoskeleton arrangement in infantile pituitary cells.
Toral C; Solano-Agama C; Reyes-Márquez B; Sabanero M; Talamás P; González del Pliego M; Mendoza-Garrido ME
Cell Tissue Res; 2007 Jan; 327(1):143-53. PubMed ID: 16941125
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
16. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
17. EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases.
DeYulia GJ; Cárcamo JM
Biochem Biophys Res Commun; 2005 Aug; 334(1):38-42. PubMed ID: 15982634
[TBL] [Abstract][Full Text] [Related]
18. An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components.
Springer TA
J Mol Biol; 1998 Nov; 283(4):837-62. PubMed ID: 9790844
[TBL] [Abstract][Full Text] [Related]
19. Creation and biophysical characterization of a high-affinity, monomeric EGF receptor ectodomain using fluorescent proteins.
Kozer N; Henderson C; Bailey MF; Rothacker J; Nice EC; Burgess AW; Clayton AH
Biochemistry; 2010 Sep; 49(35):7459-66. PubMed ID: 20715761
[TBL] [Abstract][Full Text] [Related]
20. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
